FORM OF LOCK-UP AGREEMENTLock-Up Agreement • July 3rd, 2018 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations • New York
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • November 14th, 2024 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 13th, 2024 • Bain Capital Life Sciences Fund, L.P. • Biological products, (no disgnostic substances)
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • June 23rd, 2023 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GAgreement Regarding the Joint Filing of Schedule 13g • February 14th, 2023 • Bain Capital Life Sciences Fund, L.P. • Biological products, (no disgnostic substances)
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • July 3rd, 2018 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule (including amendments thereto) jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • May 30th, 2023 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • January 22nd, 2024 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 7th, 2020 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • August 22nd, 2019 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
REGISTRATION RIGHTS AGREEMENT BY AND AMONG DYNAVAX TECHNOLOGIES CORPORATION AND CERTAIN STOCKHOLDERS DATED AS OF MARCH 11, 2020Registration Rights Agreement • March 12th, 2020 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of March 11, 2020, is made by and among:
Bain Capital Life Sciences Fund, L.P. BCIP Life Sciences Associates, LP 200 Clarendon Street Boston, MA 021163(a)(9) Exchange Agreement • March 12th, 2020 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of , 2020, is made by and among:
